These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Combination of mutated herpes simplex virus type 1 (G207 virus) with radiation for the treatment of squamous cell carcinoma of the head and neck. Kim SH; Wong RJ; Kooby DA; Carew JF; Adusumilli PS; Patel SG; Shah JP; Fong Y Eur J Cancer; 2005 Jan; 41(2):313-22. PubMed ID: 15661558 [TBL] [Abstract][Full Text] [Related]
7. Radiobiologic parameters and local effect model predictions for head-and-neck squamous cell carcinomas exposed to high linear energy transfer ions. Beuve M; Alphonse G; Maalouf M; Colliaux A; Battiston-Montagne P; Jalade P; Balanzat E; Demeyer A; Bajard M; Rodriguez-Lafrasse C Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):635-42. PubMed ID: 18234427 [TBL] [Abstract][Full Text] [Related]
8. Enhancement of cell radiation sensitivity by pegylated gold nanoparticles. Liu CJ; Wang CH; Chen ST; Chen HH; Leng WH; Chien CC; Wang CL; Kempson IM; Hwu Y; Lai TC; Hsiao M; Yang CS; Chen YJ; Margaritondo G Phys Med Biol; 2010 Feb; 55(4):931-45. PubMed ID: 20090183 [TBL] [Abstract][Full Text] [Related]
9. Design and characterization of HER-2-targeted gold nanoparticles for enhanced X-radiation treatment of locally advanced breast cancer. Chattopadhyay N; Cai Z; Pignol JP; Keller B; Lechtman E; Bendayan R; Reilly RM Mol Pharm; 2010 Dec; 7(6):2194-206. PubMed ID: 20973534 [TBL] [Abstract][Full Text] [Related]
10. Estimation of tumour dose enhancement due to gold nanoparticles during typical radiation treatments: a preliminary Monte Carlo study. Cho SH Phys Med Biol; 2005 Aug; 50(15):N163-73. PubMed ID: 16030374 [TBL] [Abstract][Full Text] [Related]
11. Applying gold nanoparticles as tumor-vascular disrupting agents during brachytherapy: estimation of endothelial dose enhancement. Ngwa W; Makrigiorgos GM; Berbeco RI Phys Med Biol; 2010 Nov; 55(21):6533-48. PubMed ID: 20959684 [TBL] [Abstract][Full Text] [Related]
12. Beam energy considerations for gold nano-particle enhanced radiation treatment. Van den Heuvel F; Locquet JP; Nuyts S Phys Med Biol; 2010 Aug; 55(16):4509-20. PubMed ID: 20668345 [TBL] [Abstract][Full Text] [Related]
13. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Karakoyun-Celik O; Norris CM; Tishler R; Mahadevan A; Clark JR; Goldberg S; Devlin P; Busse PM Head Neck; 2005 May; 27(5):353-61. PubMed ID: 15726587 [TBL] [Abstract][Full Text] [Related]
14. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience. Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834 [TBL] [Abstract][Full Text] [Related]
15. Supradose intra-arterial cisplatin and concurrent radiation therapy for the treatment of stage IV head and neck squamous cell carcinoma is feasible and efficacious in a multi-institutional setting: results of Radiation Therapy Oncology Group Trial 9615. Robbins KT; Kumar P; Harris J; McCulloch T; Cmelak A; Sofferman R; Levine P; Weisman R; Wilson W; Weymuller E; Fu K J Clin Oncol; 2005 Mar; 23(7):1447-54. PubMed ID: 15735120 [TBL] [Abstract][Full Text] [Related]
16. Parameters governing gold nanoparticle X-ray radiosensitization of DNA in solution. Brun E; Sanche L; Sicard-Roselli C Colloids Surf B Biointerfaces; 2009 Aug; 72(1):128-34. PubMed ID: 19414242 [TBL] [Abstract][Full Text] [Related]
17. Phase II clinical trial of parenteral hydroxyurea and hyper-fractionated, accelerated external beam radiation therapy in patients with advanced squamous cell carcinoma of the head and neck: toxicity and efficacy with continuous ribonucleoside reductase inhibition. Beitler JJ; Smith RV; Owen RP; Silver CE; Mazumdar M; Wadler S Head Neck; 2007 Jan; 29(1):18-25. PubMed ID: 16983691 [TBL] [Abstract][Full Text] [Related]
18. Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models. Koonce NA; Quick CM; Hardee ME; Jamshidi-Parsian A; Dent JA; Paciotti GF; Nedosekin D; Dings RP; Griffin RJ Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):588-96. PubMed ID: 26461001 [TBL] [Abstract][Full Text] [Related]
19. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Kennedy LC; Bickford LR; Lewinski NA; Coughlin AJ; Hu Y; Day ES; West JL; Drezek RA Small; 2011 Jan; 7(2):169-83. PubMed ID: 21213377 [TBL] [Abstract][Full Text] [Related]
20. Interactions of phenyldithioesters with gold nanoparticles (AuNPs): implications for AuNP functionalization and molecular barcoding of AuNP assemblies. Blakey I; Schiller TL; Merican Z; Fredericks PM Langmuir; 2010 Jan; 26(2):692-701. PubMed ID: 19824687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]